Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients

In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2015-07, Vol.26 (7), p.1511-1511
Hauptverfasser:	Fouad, T.M., de Azambuja, E., Azim, H.A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bone Density Conservation Agents - administration & dosage Breast Neoplasms - drug therapy Female Humans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol.
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdv193